CPO
GILD icon

Cerity Partners OCIO’s Gilead Sciences GILD Stock Holding History

Cerity Partners OCIO’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$10.7M Buy
124,739
+1,185
+1% +$93.8K 0.34% 43
2022
Q3 		$7.62M Buy
123,554
+6,328
+5% +$399K 0.27% 47
2022
Q2 		$7.25M Buy
117,226
+13,358
+13% +$827K 0.24% 63
2022
Q1 		$6.17M Buy
103,868
+22,210
+27% +$1.42M 0.19% 69
2021
Q4 		$5.93M Buy
81,658
+6,390
+8% +$440K 0.17% 67
2021
Q3 		$5.26M Buy
75,268
+4,738
+7% +$333K 0.17% 66
2021
Q2 		$4.86M Buy
70,530
+4,294
+6% +$287K 0.16% 71
2021
Q1 		$4.28M Buy
66,236
+41,697
+170% +$2.69M 0.15% 73
2020
Q4 		$1.43M Sell
24,539
-709
-3% -$42.8K 0.06% 137
2020
Q3 		$1.59M Sell
25,248
-1,754
-6% -$122K 0.07% 123
2020
Q2 		$2.08M Sell
27,002
-33,931
-56% -$2.6M 0.1% 102
2020
Q1 		$4.55M Sell
60,933
-116
-0.2% -$8.02K 0.26% 44
2019
Q4 		$4.2M Buy
61,049
+44,724
+274% +$2.91M 0.19% 52
2019
Q3 		$1.03M Buy
16,325
+489
+3% +$32K 0.05% 146
2019
Q2 		$1.07M Buy
15,836
+171
+1% +$11.2K 0.06% 131
2019
Q1 		$1.02M Buy
15,665
+1,069
+7% +$71.1K 0.06% 127
2018
Q4 		$913K Buy
14,596
+1,492
+11% +$104K 0.06% 146
2018
Q3 		$1.01M Sell
13,104
-8,659
-40% -$654K 0.06% 130
2018
Q2 		$1.54M Buy
21,763
+268
+1% +$18.9K 0.1% 84
2018
Q1 		$1.62M Buy
21,495
+10,371
+93% +$824K 0.1% 86
2017
Q4 		$797K Buy
11,124
+383
+4% +$29.1K 0.05% 148
2017
Q3 		$869K Sell
10,741
-2,725
-20% -$208K 0.06% 126
2017
Q2 		$953K Sell
13,466
-639
-5% -$42.5K 0.07% 112
2017
Q1 		$957K Buy
14,105
+808
+6% +$56.8K 0.08% 127
2016
Q4 		$954K Buy
13,297
+934
+8% +$69.4K 0.08% 118
2016
Q3 		$978K Buy
12,363
+1,955
+19% +$159K 0.09% 102
2016
Q2 		$858K Buy
10,408
+883
+9% +$78.4K 0.09% 108
2016
Q1 		$875K Buy
9,525
+379
+4% +$34.2K 0.09% 108
2015
Q4 		$925K Buy
+9,146
New +$952K 0.1% 90

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cerity Partners OCIO's GILD Position: Q4 2022 in Review

Cerity Partners OCIO increased its Gilead Sciences (GILD) stake by 0.96% in Q4 2022, buying an estimated $93.8K and bringing the position to 124,739 shares worth $10.7M. The position accounts for 0.34% of the portfolio, ranked #43.

Cerity Partners OCIO first reported a position in GILD in Q4 2015 and has held it in 29 quarters since. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Cerity Partners OCIO held 124,739 shares of Gilead Sciences worth $10.7M as of Q4 2022.
  • Cerity Partners OCIO bought 1,185 Gilead Sciences shares in Q4 2022, an estimated $93.8K.
  • Gilead Sciences made up 0.34% of Cerity Partners OCIO's portfolio in Q4 2022, its #43 holding.
  • Cerity Partners OCIO first reported a position in Gilead Sciences in Q4 2015 and has held it in 29 quarters since.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.